1
« Last post by Indy on Today at 12:33:48 AM »
So I know this forum isn't very lively but I'd love for it to see some new life, I'm an OG from the opiophile days.
Anyway, after being on methadone for years, clean from opioids, I developed a drinking problem that got really really bad at times.
What finally reined it in for me was the combination of gabapentin and acamprosate. But I love gabapentin now, and I always run out early because of that.
Does anyone know if there are any research chem style gabapentinoids? I did have experience with phenibut long ago, does anyone know if phenibut would prevent one from experiencing gabapentin withdrawal? I know they have some actions in common but I haven't had phenibut in years.
Does anyone else love gabapentinoids? I love them for helping me get and stay off the sauce, but also on their own I find them very motivating and almost like a nootropic for me.
Any random thoughts about gabapentin/gabapentinoids?
PS Chipper I think for such low activity, you have the forum splintered into too many categories. Just IMO.
2
« Last post by smfadmin on Yesterday at 11:54:55 AM »
10 Important Facts About Attraction
1. A bit of mystery can attract attention
Not sharing everything at once can create curiosity. But being distant all the time can push people away.
2. Smiling matters
A warm smile usually makes a person look friendly and safe. Many people respond well to it.
3. Familiarity builds attachment
People often feel drawn to what feels familiar, even when it is not always good for them.
4. Voice can change with interest
When someone feels attracted, their tone or pitch may shift slightly without them noticing.
5. Decisions can vary by person
Some people change their minds more often than others. It depends more on personality than gender.
6. Humor helps a lot
A natural sense of humor makes interactions easy and enjoyable. It often builds connection.
7. Eye contact shows interest
Holding eye contact a bit longer than usual can signal attraction, but too much can feel uncomfortable.
8. Arguing can mean involvement
People often argue more with those they care about. Silence can sometimes mean distance.
9. Different ways of handling problems
Some people focus more on feelings, others on solutions. Both styles exist in men and women.
10. Body language creates first impression
Posture, stance, and movement strongly affect how others see you in the first few seconds.
Attraction usually comes from a mix of behavior, communication, and how a person makes others feel, not just one trait.
3
« Last post by olivianaylor on March 26, 2026, 02:59:38 PM »
The forum thread you shared reflects how online communities discuss drug use, experiences, and harm-reduction advice. Such platforms allow users to exchange personal insights, safety tips, and support, often based on real-life experiences rather than formal research. Studies show these forums commonly focus on sharing advice, effects, and risk awareness among members. Similarly, in professional fields like project management, learners benefit from shared guidance and structured support. Just as forums help users make informed decisions, those preparing for certifications can rely on PMI-ACP test help online to gain practical knowledge, expert tips, and confidence needed to succeed in agile project environments.
4
« Last post by smfadmin on March 21, 2026, 06:52:03 AM »
https://www.psychiatrist.com/pcc/recreational-ketamine-induced-uropathy/?utm_source=Klaviyo&utm_medium=email&utm_campaign=news_wmr&klid=01HYSTTNXNB74YAYKT9XMYQCN0&_kx=va3uRF3O8-7Dg_zjrKMZJk0wdery-TOTVyZ3l8muM1g.VpkqxCMarch 19, 2026 Ketamine is a phencyclidine derivative with N-methyl-D-aspartate receptor antagonist properties used for decades as an anesthetic and analgesic. At subanesthetic doses, it produces dissociative and psychotropic effects, prompting inquiry into its utility for psychiatric conditions. Racemic ketamine, a mixture of equal parts R- and S-enantiomers, has been studied off-label for treatment-resistant depression and other psychiatric disorders.1 More recently, intranasal S-ketamine (esketamine) received US Food and Drug Administration approval for treatment-resistant depression. Outside of clinical settings, ketamine has a long history of nonmedical use. Early surveys in the 1990s documented recreational use in clubs, concerts, and “rave” environments, driven by its dissociative and hallucinogenic properties. In the United States, population-based survey data indicate that recreational ketamine use, while still uncommon, has increased over the past decade. Analyses from the National Survey on Drug Use and Health show that past-year ketamine use among adults increased by 81% from 0.11% in 2015 to 0.20% in 2019 and subsequently increased by 40% from 0.20% in 2021 to 0.28% in 2022, suggesting growing population-level exposure.2 Adults reporting past-year ketamine use were initially concentrated in younger age groups, but more recent increases have been observed among adults aged 26–34 years, indicating a broadening demographic of recreational users.2,3 Complementing these survey findings, drug seizure records demonstrate a substantial increase in illicit ketamine availability in the United States between 2017 and 2022.4 Illicit ketamine is obtained through several channels. Historically, supplies have come from veterinary diversion, international trafficking, or local synthesis. Some users acquire ketamine through dark web marketplaces, purchased with cryptocurrency to maintain anonymity.5 More recently, concerns have arisen about telehealth prescribing platforms that provide ketamine with little or no formal evaluation for off-label psychiatric indications,6 with some patients escalating doses or diverting medication for nonmedical use. This evolving access underscores the overlap between therapeutic exposure and recreational misuse. Recreational ketamine can be acquired in liquid or powder forms. Powdered ketamine is commonly insufflated. Liquid ketamine is injected intravenously or intramuscularly or, less commonly, ingested orally or used rectally.7,8 Orally ingested ketamine is rapidly metabolized to norketamine, producing more of a sedative and less of a psychedelic experience.7 Compared with oral use, intranasal or parenteral administration provides faster onset and greater intensity of dissociative effects. Street formulations vary in purity, and slang terms such as “Special K,” “Vitamin K,” or “Kit-Kat” reflect its reputation in recreational drug culture. The reinforcing appeal of ketamine lies in its rapid onset of euphoria, increased sociability, dissociation, and altered perception of time and space.7,8 Its relatively short duration of action, low cost, and accessibility make it attractive to those seeking intense psychoactive experiences.9 Tolerance develops quickly, necessitating escalating doses to achieve similar effects,9 increasing the risks of psychiatric and physical complications. Chronic, heavy use has been strongly linked to ketamine-induced uropathy (KIU),10,11 which typically presents with cystitis-like lower urinary tract symptoms (LUTS).12,13 KIU can progress to severe bladder and upper urinary tract injury if use continues.14,15 Despite increasing recognition in urologic literature, KIU remains underrecognized in psychiatric and primary care settings, leading to extensive evaluation for infection or interstitial cystitis, repeated empirical antibiotic treatment despite negative urine cultures, and disease progression.16,17 Without awareness of ketamine exposure, the underlying etiology may go undetected, delaying appropriate treatment and drug cessation. For primary care physicians, psychiatrists, and other mental health providers, consideration of recreational ketamine use is therefore essential when patients present with unexplained urinary complaints. Here, we present 2 cases that illustrate the psychiatric and urologic consequences of KIU. These reports highlight the diagnostic challenges posed by KIU, the role of psychiatric comorbidity in ongoing use, and the need for multidisciplinary management. Go to the link full the case studies.
5
« Last post by smfadmin on March 09, 2026, 01:07:16 PM »
6
« Last post by smfadmin on March 09, 2026, 01:25:24 AM »
https://neurosciencenews.com/cocaine-brain-rewiring-deltafosb-30246/
Cocaine Addiction is a Biological Rewiring, Not a ChoiceMarch 4, 2026 Summary: Relapse isn’t a failure of willpower—it’s a biological “rewiring” of the brain. A new study reveals how chronic cocaine use hijacks the connection between the brain’s reward center and its memory hub (the hippocampus). Researchers identified a specific protein, DeltaFosB, that acts like a genetic master switch. As cocaine use continues, this protein accumulates, turning certain genes on and off to create a permanent, compulsive drive for the drug. By using CRISPR technology to pinpoint this mechanism, scientists have opened the door to a new class of “addiction-breaking” medications that could one day reset the brain’s circuitry and prevent relapse. Key Facts The “Master Switch”: The protein DeltaFosB accumulates in the brain’s reward-memory circuit during chronic cocaine use, making it harder to quit and easier to relapse. Rewiring the Hippocampus: Cocaine use doesn’t just change how you feel; it physically alters the hippocampus, the brain’s memory center, linking drug-seeking behavior to deep-seated survival instincts. Calreticulin’s Role: Researchers found a secondary gene, calreticulin, that is controlled by DeltaFosB and helps “rev the brain’s engine” to seek out more cocaine. No Approved Meds: Currently, there are no FDA-approved medications to treat cocaine addiction. This research identifies DeltaFosB as a primary target for future pharmaceutical therapies. CRISPR Insights: Scientists used specialized CRISPR technology to prove that DeltaFosB isn’t just associated with addiction—it is necessary for the brain changes that drive it. When a cocaine addict relapses, it isn’t a matter of personal failure — it’s the biological result of their brain’s rewiring, new research finds.Michigan State University scientists found that cocaine changes how the hippocampus functions, contributing to the ongoing compulsion to seek out the drug. Their National Institutes of Health-supported research, published in Science Advances, not only explains why cocaine addiction is notoriously difficult to treat, but it could also help scientists develop new pharmaceutical therapies. “Addiction is a disease in the same sense as cancer,” said senior author A.J. Robison, a professor of neuroscience and physiology. “We need to find better treatments and help people who are addicted in the same sense that we need to find cures for cancer.” At least a million people nationwide struggle with cocaine addiction, and right now, there’s no FDA-approved medication to treat it. People who stop using don’t experience the same physical withdrawal symptoms that opiates cause, but that doesn’t mean it’s easy to quit. The drug hijacks the brain, flooding the reward centers with dopamine. This positive reinforcement tricks the brain into feeling like it’s doing something good instead of destructive. Even if someone successfully quits, the odds aren’t in their favor. About 24% relapse to weekly use, and another 18% return to a treatment program within a year. Andrew Eagle, a former postdoctoral researcher in Robison’s lab and the paper’s lead author, found a key player responsible for the compulsion — a protein called DeltaFosB. He used a specialized form of CRISPR technology to examine the role this protein plays in specific brain circuits when mice were exposed to cocaine. Using mouse models, he learned that this protein acts like a switch, turning genes on and off in the circuit between the brain’s reward center and the hippocampus, the brain’s memory hub. The longer someone uses cocaine, the more this protein accumulates in the circuit. This protein changes how the neurons function, altering how the circuit responds to cocaine. “This protein isn’t just associated with these changes, it is necessary for them,” Eagle said. “Without it, cocaine does not produce the same changes in brain activity or the same strong drive to seek out the drug.” The research team also found another group of genes controlled by DeltaFosB after chronic cocaine use. One of those genes, called calreticulin, helps regulate how neurons communicate with each other. Their work showed calreticulin contributes to revving the brain’s engine to compulsively seek out more cocaine. Key Questions Answered: Q: Is cocaine addiction a choice or a disease? A: This research confirms it is a biological disease. Chronic use physically alters the brain’s genetic expression, creating a protein buildup that forces the brain to prioritize the drug over everything else. It’s a “rewiring” that willpower alone often cannot overcome. Q: Why is it so hard to stop “craving” the drug even months later? A: Because the drug hijacks your memory center (the hippocampus). The protein DeltaFosB creates a long-lasting “switch” in your neural circuits that stays flipped long after the drug has left your system, keeping the drive to seek it out active. Q: Is there a “cure” on the horizon? A: While we aren’t there yet, researchers are currently developing compounds specifically designed to block DeltaFosB from binding to DNA. If successful, these could “reset” the addicted brain and make long-term recovery much more achievable.
7
« Last post by gwenmallard on March 04, 2026, 10:06:38 AM »
This is a sophisticated scientific discussion! To ensure your contribution remains highly relevant to a school-aged learning audience while maintaining SEO value for uniccm/school, the content needs to bridge the gap between complex molecular biology and foundational educational concepts. Below is a drafted forum post designed to fit the flow of the existing conversation. It highlights the transition from "prebiotic soup" to structured cellular life—a core topic in biology curricula. Bridging the Gap: From Primordial Lipids to the Classroom The hypothesis regarding the interaction between primordial lipids, amino acids, and PAH scaffolds provides a compelling look at the "engineering" phase of early life. For students and educators, understanding this transition is key to grasping how simple chemical reactions evolved into the complex genomic structures we study in biology today. The Structural Evolution: Why Histones Matter As the discussion noted, the leap from prokaryotic (circular) DNA to eukaryotic (linear) DNA necessitated a sophisticated filing system. Without histones, the several meters of DNA in a human cell would be a tangled, unusable mess. Educational Context: In a school setting, we often use the "thread on a spool" analogy. Histones are the spools that prevent the genetic thread from knotting, allowing for the precise "reading" of genes (transcription). The Epigenetic Layer: The mention of methylation and acetylation is particularly relevant for modern science curricula. It teaches students that our "genetic destiny" isn't just about the sequence of A, T, C, and G, but about the chemical "switches" that turn those sequences on or off. Relevance to Student Learning and Health The forum's interest in substance use and harm reduction actually intersects with this molecular biology. Modern research suggests that environmental factors—including nutrition and exposure to toxins—can leave epigenetic marks on our histones. For students exploring these topics at UNICCM, learning about the histone-DNA complex isn't just about passing a biology exam; it’s about understanding how our environment and choices interact with our very blueprint at a molecular level.
8
« Last post by smfadmin on February 24, 2026, 04:52:08 AM »
https://neurosciencenews.com/ai-chatbot-mental-health-delusions-30178/Chatbots Can Worsen Delusions and ManiaFebruary 23, 2026 Summary: For many, AI chatbots are a helpful tool for productivity, but for those with severe mental illness, they may be a dangerous “echo chamber.” A new study warns that AI chatbots like ChatGPT can significantly worsen psychiatric conditions—particularly delusions, mania, and suicidal ideation. By screening the health records of over 54,000 patients, researchers found that the AI’s tendency to validate a user’s beliefs can consolidate grandiose or paranoid thoughts, turning a digital assistant into a fuel for psychosis. Key Facts Validation Trap: AI chatbots are designed to be helpful and agreeable, which means they often inadvertently validate a user’s delusions rather than challenging them. Risk Groups: The study highlights significant risks for patients with severe mental illnesses such as schizophrenia or bipolar disorder. Worsening Symptoms: Negative consequences identified include worsened grandiose delusions, paranoia, mania, suicidal ideation, and eating disorders. Tip of the Iceberg: Researchers identified 38 specific cases in health records but believe the actual number of affected patients is likely much higher and remains undetected. Regulation Required: The research team is calling for central regulation of AI technology, similar to how social media is now being regulated to protect the mental health of children and young people. People with mental illness who use AI chatbots risk experiencing a worsening of their condition.
This is shown by a new study published in the international journal Acta Psychiatrica Scandinavica. The researchers screened electronic health records from nearly 54,000 patients with mental illness and found several cases in which the use of AI chatbots appears to have had negative consequences – primarily in the form of worsened delusions, but also potential worsening of mania, suicidal ideation, and eating disorder. “It supports our hypothesis that the use of AI chatbots can have significant negative consequences for people with mental illness,” says Professor Søren Dinesen Østergaard from Aarhus University and Aarhus University Hospital, who leads the research group behind the study. See the link for the full article ...
|
Recent Posts
